In situ growth of luminescent d-f MOF nanostructures on bacterial cellulose as an accessible kit for early jaundice diagnosis

During the initial week after birth, a majority of newborns experience hyperbilirubinemia and jaundice as a result of the build-up of unconjugated Bilirubin (BR) in their bloodstream. If elevated BR levels are not adequately addressed, it could result in brain damage. Despite advancements in luminescence-based sensing technology for clinical purposes, there remains a significant demand for diagnostic devices with accurate, specific, portable, and affordable features. We present a luminescent nanopaper-based assay kit for visual recognition of BR. This novel kit comes with a smartphone readout, enabling effortless recognition of BR. To develop the kit, a new d - f heterometallic MOF {[Ce<sub>2</sub>Zn(pzdc)<sub>4</sub>(H<sub>2</sub>O)<sub>6</sub>]·2H<sub>2</sub>O}<sub>n</sub> (pzdc = 2,3-pyrazinedicarboxylic acid) (CeZn-MOF) with advantageous photophysical features was grown on bacterial cellulose (BC) nanofibers to form BC@CeZn-MOF platform. The platform's luminescence quenches in the presence of BR with a turn-off mechanism originating from Inner Filter Energy (IFE). The luminescence quenching was linearly proportional to the concentration of BR in range of 0.1 - 20 mg.dL<sup>- 1</sup> (LOD = 0.027 mg.dL<sup>- 1</sup>), and recognition of small amount of BR could be attained with a smartphone camera. Furthermore, the luminescence emission of the sensing platform was recovered upon UV light (470 nm) through photo-isomerizing of BR into lumirubin as a non-PL quencher. The kit's feasibility was confirmed through validating its practicality for detecting BR in human serum samples and its compatibility with clinical procedures. The non-poisonous nature and distinctive photophysical characteristics of platform makes it an excellent choice, easy-to-use BR recognition assay kit.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2025-05-09
DOI
https://doi.org/10.1038/s41598-025-94147-2
Citations
3
Primary Topic
Nanoplatforms for cancer theranostics
Type
article
Field-Weighted Citation Impact
2.02

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

In situ growth of luminescent d-f MOF nanostructures on bacterial cellulose as an accessible kit for early jaundice diagnosis

Faezeh Moghzi, Janet Soleimannejad, Arash Farahmand Kateshali, Jan Janczak
3 citations
Scientific Reports
Nanoplatforms for cancer theranostics
2.02
article

In situ growth of luminescent d-f MOF nanostructures on bacterial cellulose as an accessible kit for early jaundice diagnosis

Faezeh Moghzi, Janet Soleimannejad, Arash Farahmand Kateshali, Jan Janczak
article en
3 citations

Abstract

During the initial week after birth, a majority of newborns experience hyperbilirubinemia and jaundice as a result of the build-up of unconjugated Bilirubin (BR) in their bloodstream. If elevated BR levels are not adequately addressed, it could result in brain damage. Despite advancements in luminescence-based sensing technology for clinical purposes, there remains a significant demand for diagnostic devices with accurate, specific, portable, and affordable features. We present a luminescent nanopaper-based assay kit for visual recognition of BR. This novel kit comes with a smartphone readout, enabling effortless recognition of BR. To develop the kit, a new d - f heterometallic MOF {[Ce<sub>2</sub>Zn(pzdc)<sub>4</sub>(H<sub>2</sub>O)<sub>6</sub>]·2H<sub>2</sub>O}<sub>n</sub> (pzdc = 2,3-pyrazinedicarboxylic acid) (CeZn-MOF) with advantageous photophysical features was grown on bacterial cellulose (BC) nanofibers to form BC@CeZn-MOF platform. The platform's luminescence quenches in the presence of BR with a turn-off mechanism originating from Inner Filter Energy (IFE). The luminescence quenching was linearly proportional to the concentration of BR in range of 0.1 - 20 mg.dL<sup>- 1</sup> (LOD = 0.027 mg.dL<sup>- 1</sup>), and recognition of small amount of BR could be attained with a smartphone camera. Furthermore, the luminescence emission of the sensing platform was recovered upon UV light (470 nm) through photo-isomerizing of BR into lumirubin as a non-PL quencher. The kit's feasibility was confirmed through validating its practicality for detecting BR in human serum samples and its compatibility with clinical procedures. The non-poisonous nature and distinctive photophysical characteristics of platform makes it an excellent choice, easy-to-use BR recognition assay kit.

Scientific ReportsVol. 15(1)
University of Tehran (IR), Polish Academy of Sciences (PL)
National Science Foundation, Tehran University of Medical Sciences and Health Services
Zero hunger
Openalex Percentile: Top 14%
Nanoplatforms for cancer theranostics
2.02
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.